Back to top
more

Unum Therapeutics Inc. (UMRX)

(Delayed Data from NSDQ)

$3.35 USD

3.35
22,165

+0.07 (2.13%)

Updated May 3, 2019 04:13 PM ET

After-Market: $3.32 (%) 5:22 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.15%
2Buy17.88%
3Hold9.47%
4Sell5.14%
5Strong Sell2.57%
S&P50011.11%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

NA Value NA Growth NA Momentum NA VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

NA

Industry: NA

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Brokerage Reports

0 items in cart

Cogent Biosciences, Inc. [UMRX]

Reports for Purchase

Showing records 1 - 20 ( 55 total )

Company: Cogent Biosciences, Inc.

Industry: Medical - Biomedical and Genetics

Record: 1

10/06/2020

Daily Note

Pages: 11

MORNING CALL

Provider: WEDBUSH SECURITIES INC.

Analyst: Research Department

Price: 25.00

Research Provided by a Third Party

Company: Cogent Biosciences, Inc.

Industry: Medical - Biomedical and Genetics

Record: 2

10/05/2020

Company Report

Pages: 7

Cogitating on Cogent

Provider: WEDBUSH SECURITIES INC.

Analyst: NIERENGARTEN D

Price: 25.00

Research Provided by a Third Party

Company: Cogent Biosciences, Inc.

Industry: Medical - Biomedical and Genetics

Record: 3

08/24/2020

Daily Note

Pages: 14

MORNING CALL

Provider: WEDBUSH SECURITIES INC.

Analyst: Research Department

Price: 50.00

Research Provided by a Third Party

Company: Cogent Biosciences, Inc.

Industry: Medical - Biomedical and Genetics

Record: 4

08/23/2020

Company Report

Pages: 16

Ready to Play Ball with PLX9486

Provider: WEDBUSH SECURITIES INC.

Analyst: NIERENGARTEN D

Price: 50.00

Research Provided by a Third Party

Company: Cogent Biosciences, Inc.

Industry: Medical - Biomedical and Genetics

Record: 5

08/12/2020

Company Report

Pages: 6

No Longer Numb

Provider: WEDBUSH SECURITIES INC.

Analyst: NIERENGARTEN D

Price: 25.00

Research Provided by a Third Party

Company: Cogent Biosciences, Inc.

Industry: Medical - Biomedical and Genetics

Record: 6

08/12/2020

Daily Note

Pages: 8

MORNING CALL

Provider: WEDBUSH SECURITIES INC.

Analyst: Research Department

Price: 25.00

Research Provided by a Third Party

Company: Cogent Biosciences, Inc.

Industry: Medical - Biomedical and Genetics

Record: 7

07/07/2020

Daily Note

Pages: 10

MORNING CALL

Provider: WEDBUSH SECURITIES INC.

Analyst: Research Department

Price: 25.00

Research Provided by a Third Party

Company: Cogent Biosciences, Inc.

Industry: Medical - Biomedical and Genetics

Record: 8

07/07/2020

Company Report

Pages: 8

CORRECTED: Upgrading to OUTPERFORM; UMRX Gets a Break of that KIT(-Kat Bar)

Provider: WEDBUSH SECURITIES INC.

Analyst: NIERENGARTEN D

Price: 25.00

Research Provided by a Third Party

Company: Cogent Biosciences, Inc.

Industry: Medical - Biomedical and Genetics

Record: 9

05/16/2020

Company Report

Pages: 7

Dropping Coverage

Provider: H.C. Wainwright & Co., Inc.

Analyst: FEIN A

Price: 25.00

Research Provided by a Third Party

Company: Cogent Biosciences, Inc.

Industry: Medical - Biomedical and Genetics

Record: 10

05/12/2020

Company Report

Pages: 5

Q1, BOXR Needs Help to Get Off the Mat

Provider: WEDBUSH SECURITIES INC.

Analyst: NIERENGARTEN D

Price: 10.00

Research Provided by a Third Party

Company: Cogent Biosciences, Inc.

Industry: Medical - Biomedical and Genetics

Record: 11

03/27/2020

Company Report

Pages: 6

Awaiting Clinical Validation for the BOXR Platform

Provider: H.C. Wainwright & Co., Inc.

Analyst: FEIN A

Price: 25.00

Research Provided by a Third Party

Company: Cogent Biosciences, Inc.

Industry: Medical - Biomedical and Genetics

Record: 12

03/27/2020

Company Report

Pages: 5

4Q19 earnings- Earlier this month.

Provider: WEDBUSH SECURITIES INC.

Analyst: NIERENGARTEN D

Price: 10.00

Research Provided by a Third Party

Company: Cogent Biosciences, Inc.

Industry: Medical - Biomedical and Genetics

Record: 13

03/27/2020

Daily Note

Pages: 9

MORNING CALL

Provider: WEDBUSH SECURITIES INC.

Analyst: Research Department

Price: 25.00

Research Provided by a Third Party

Company: Cogent Biosciences, Inc.

Industry: Medical - Biomedical and Genetics

Record: 14

03/04/2020

Company Report

Pages: 5

Downgrading to NEUTRAL; Will this BOXR Get Off the Mat?

Provider: WEDBUSH SECURITIES INC.

Analyst: NIERENGARTEN D

Price: 10.00

Research Provided by a Third Party

Company: Cogent Biosciences, Inc.

Industry: Medical - Biomedical and Genetics

Record: 15

03/04/2020

Daily Note

Pages: 12

MORNING CALL

Provider: WEDBUSH SECURITIES INC.

Analyst: Research Department

Price: 25.00

Research Provided by a Third Party

Company: Cogent Biosciences, Inc.

Industry: Medical - Biomedical and Genetics

Record: 16

12/09/2019

Industry Report

Pages: 12

ASH 2019: Key Presentations Roundup for Covered Companies Days 1-2

Provider: WEDBUSH SECURITIES INC.

Analyst: NIERENGARTEN D

Price: 25.00

Research Provided by a Third Party

Company: Cogent Biosciences, Inc.

Industry: Medical - Biomedical and Genetics

Record: 17

11/14/2019

Company Report

Pages: 5

Initial Solid Tumor Data on Track to Readout by Year end

Provider: H.C. Wainwright & Co., Inc.

Analyst: FEIN A

Price: 10.00

Research Provided by a Third Party

Company: Cogent Biosciences, Inc.

Industry: Medical - Biomedical and Genetics

Record: 18

11/13/2019

Company Report

Pages: 8

BOXR Getting Ready to Fight

Provider: WEDBUSH SECURITIES INC.

Analyst: NIERENGARTEN D

Price: 25.00

Research Provided by a Third Party

Company: Cogent Biosciences, Inc.

Industry: Medical - Biomedical and Genetics

Record: 19

11/07/2019

Daily Note

Pages: 3

Eyeing the Bigger Prize; Reit Buy and $18 PT

Provider: H.C. Wainwright & Co., Inc.

Analyst: FEIN A

Price: 10.00

Research Provided by a Third Party

Company: Cogent Biosciences, Inc.

Industry: Medical - Biomedical and Genetics

Record: 20

11/05/2019

Company Report

Pages: 8

Looking Better with Bolt-ons

Provider: WEDBUSH SECURITIES INC.

Analyst: NIERENGARTEN D

Price: 25.00

Research Provided by a Third Party